Nonetheless, statistical analyses drawing upon online databases, such as TCGA, insinuate a close association between SPC25 expression and poor prognosis in patients with hepatocellular carcinoma (HCC), non-small cell lung adenocarcinoma cells, and prostate cancer. The gene discussed is SPC25; the disease is prostate carcinoma.